



















Comprehensive analyses of biomarkers predicting therapeutic effect of an 
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研究成果の概要（英文）：This study was designed to identify biomarkers (BMs) predicting therapeutic 
effect of an anti-VEGF antibody, bevacizumab against advanced colorectal cancer. Pre- and 
post-treatment (Tx) serum concentrations of VEGF, pre-Tx cytokine/chemokine profile, and miRNA 
released after stimulation of human umbilical vein endothelial cells (HUVEC) with VEGF were assayed 
to select candidate BMs. 
   Serum concentration of post-Tx Bmab-unconjugated VEGF was significantly higher in non-responders.
 Comprehensive analysis of pre-Tx cytokines/chemokines revealed that serum concentrations of IL-10 
and VEGF were elevated in non-responsive patients. Moreover, patients with higher concentrations of 
these cytokines showed significantly worse prognosis. These data collectively suggest that IL-10 and
 VEGF can be predictive BMs. We are currently under investigation by using blood samples obtained 
from patients to clarify the usefulness of the selected miRNAs through in vitro stimulation of HUVEC
 with VEGF.
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